°øÁö»çÇ×

2024³â ´ëÇѾÏÇÐȸ Çмú»ó ¼ö»óÀÚ
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
ÀÛ¼ºÀÏ
2024-06-27
Á¶È¸
302
2024³â ´ëÇѾÏÇÐȸ Çмú»ó ¼ö»óÀÚ ¸í´Ü
1. Á¦ 16ȸ ´ëÇѾÏÇÐȸ ¿ì¼ö³í¹®»ó (CRTÀú³Î¿¡ °ÔÀçµÈ ³í¹® Áß ±âÃÊ 2Æí, ÀÓ»ó ¹× Áß°³ 5Æí, »ó±Ý °¢ 200¸¸¿ø)
No.ºÐ¾ßÃ¥ÀÓÀúÀÚ/ 1ÀúÀÚ ³í¹®Á¦¸ñ
1 ±âÃÊ ¼­¿ïÀÇ´ë ³»°ú ±è³ª¿µ Changes in Gut Microbiome Upon Orchiectomy and Testosterone Administration in AOM/DSS-Induced Colon Cancer Mouse Model
¼­¿ïÀÇ´ë ³»°ú ¼ÛÁøÈñ
2 ±âÃÊ ¿ï»êÀÇ´ë º´¸®°ú Á¶¿µ¹Ì PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI–Resistant Metastatic Clear Cell Renal Cell Carcinoma
¿ï»êÀÇ´ë º´¸®°ú Á¤¼¼¿î
3 ÀÓ»ó ±¹¸³¾Ï¼¾ÅÍ ¾Ï¿¹¹æ»ç¾÷°ú ¿ÀÁø°æ Adherence to Cancer Prevention Guidelines and Cancer Incidence and Mortality: A Population-Based Cohort Study
4 ÀÓ»ó °í·ÁÀÇ´ë ³»°ú ¹Ú°æÈ­ PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
°í·ÁÀÇ´ë ³»°ú ±èÁÖ¿ø
5 ÀÓ»ó ¼º±Õ°üÀÇ´ë º´¸®°ú ÃÖÀ±¶ó
¿ï»êÀÇ´ë º´¸®°ú ±èÁöÈÆ
Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing–Based NTRK Fusion Detection in South Korea
°Ç±¹ÀÇ´ë º´¸®°ú À̽ÂÀº
¼º±Õ°üÀÇ´ë º´¸®°ú À̹̼÷
6 ÀÓ»ó ¼­¿ïÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú ½Å°æȯ Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy
¼­¿ïÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú ±èµµ¿í
7 Áß°³ ¼º±Õ°üÀÇ´ë ³»°ú ±è¿ø¼® Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
¼º±Õ°üÀÇ´ë ³»°ú
±è¼®Áø, ±è¿¬Á¤, À±»óÀº
2. Á¦ 14ȸ ¸ÓÅ© ¾ÏÇмú»ó (CRT¿¡ °ÔÀçµÈ ÀÓ»ó³í¹® Áß ´ëÀå¾Ï, µÎ°æºÎ, Æó¾Ï, ¹æ±¤¾Ï ³í¹®, »ó±Ý °¢ 200¸¸¿ø)
No.Ã¥ÀÓÀúÀÚ/ 1ÀúÀÚ³í¹®Á¦¸ñ
1 ¿ï»êÀÇ´ë ³»°ú ÃÖâ¹Î Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015
¿ï»êÀÇ´ë ³»°ú Àü´Ù¼Ø, ±èȣö
2 ¿ï»êÀÇ´ë ³»°ú ÀÌÀçö Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
¿ï»êÀÇ´ë ³»°ú ÀÌÀåÈ£
¿¬¼¼ÀÇ´ë ³»°ú ±èÀº¿µ
3 ºÎ»êÀÇ´ë ³»°ú ¾öÁß¼· The Additive Impact of Transbronchial Cryobiopsy Using a 1.1-mm Diameter Cryoprobe on Conventional Biopsy for Peripheral Lung Nodules
ºÎ»êÀÇ´ë ³»°ú ±è¼öÇÑ, ¸ñÁ¤ÇÏ
4 °¡Å縯ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú ÀÌÁ¾ÈÆ Differential Perspectives by Specialty on Oligometastatic Colorectal Cancer: A Korean Oligometastasis Working Group’s Comparative Survey Study
¼º±Õ°üÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú Á¶¿ø°æ, À¯±Ô»ó
5 ¼º±Õ°üÀÇ´ë ³»°ú ¹Ú¼¼ÈÆ Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
¼º±Õ°üÀÇ´ë ³»°ú ±èÈ«½Ä
ºñ´¢ÀÇÇаú Á¤º´Ã¢
3. Á¦ 13ȸ ±¤µ¿¾ÏÇмú»ó
1) ÃÖ°í IF SCI ÇмúÁö¿¡ ³í¹®À» ¹ßÇ¥ÇÑ ±âÃÊ ¹× ÀÓ»ó ºÐ¾ßÀÇ Ã¥ÀÓÀúÀÚ °¢ 1¸í
NoºÐ¾ßÃ¥ÀÓÀúÀÚ³í¹®Á¦¸ñ°ÔÀçÇмúÁö
1 ±âÃÊ °æºÏÀÇ´ë »ýÈ­Çб³½Ç À̺´Çå Peptides as multifunctional players in cancer therapy Exp Mol Med.
2023;55(6):1099-1109
2 ÀÓ»ó °í·ÁÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú ÀÓäȫ Role of local ablative treatment in oligometastatic non-small cell lung cancer: a meta-analysis Int J Surg.
2023;109(4):1006-1014
2) ´Ù¼öÀÇ SCI µîÀç ÇмúÁö¿¡ ³í¹®À» ¹ßÇ¥ÇÑ Ã¥ÀÓ ÀúÀÚ 1¸í
NoºÐ¾ßÃ¥ÀÓÀúÀÚ³í¹®Á¦¸ñ°ÔÀçÇмúÁö
1 ´Ù¼ö ¹ßÇ¥ ±¹¸³¾Ï¼¾ÅÍ ¾Ï°ü¸®Çаú ±èÁ¤¼± A comparison of machine learning models and Cox proportional hazards models regarding their ability to predict the risk of gastrointestinal cancer based on metabolic syndrome and its components ¿Ü 7Æí Front Oncol.
2023:13:1049787
4. Á¦16ȸ ´ëÇѾÏÇÐȸÁö Best Reviewer»ó (4¸í ¼±Á¤, »ó±Ý °¢ 100¸¸¿ø)
: ÃÖ±Ù 2³â°£, 2022³â 1¿ù ~ 2023³â 12¿ù±îÁö ½É»çÇÑ À§¿øÀ¸·Î ½É»ç±â°£À» ÁؼöÇÏ°í, ½É»çÀÇ °´°ü¼º, Ÿ´ç¼º, °Ç¼³ÀûÀÎ ÀÇ°ßÀ¸·Î ³í¹®ÀÇ ÁúÀû Çâ»ó¿¡ ±â¿©ÇÑ ½É»çÀ§¿ø ¼±Á¤
¼ö»óÀÚ
À±´öÇö(¿ï»êÀÇ´ë Ç÷¾×³»°ú) ±è¹ü¼®(¼­¿ïÀÇ´ë Á¾¾ç³»°ú)
¹Ú¿µ½Ä(¼­¿ïÀÇ´ë È£Èí±â³»°ú) ±è°æȯ(¿¬¼¼ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú)